Focus and Scope

Reciprocal interdependence between infectious and hematologic diseases (malignant and non-malignant) is well known. This relationship is particularly evident in Mediterranean countries. Parasitosis as Malaria, Leishmaniosis, B Hookworms, Teniasis, very common in the southeast Mediterranean area, infect about a billion people and manifest prevalently with anemia, so that they are usually diagnosed mostly by experienced hematologist on blood or bone marrow smear. On the other hand, infections are also a significant problem in patients affected by hematological malignancies. The blood is the primary vector of HIV infection, which otherwise manifest with symptoms related to a reduction in T lymphocytes. In turn, infections can favor the insurgency of hematological malignancies. The causative relationship between Epstein-Barr virus infection, Helicobacter pylori,  hepatitis C virus, HIV and lymphoproliferative diseases is well known.

Editorials from editors (specialist in hematology and infectious diseases) or comments will be welcomed to highlight particularly relevant articles appeared on this journal or in the more prestigious international journals. MJHID will be a leading journal on subjects of current importance in clinical hematology and infectious diseases. Every issue would have, besides the editor in chief, a guest editor. Both editors provide to invite experts on the selected topic to perform a complete update of the arguments readily available for practicing physician. The journal will also have a section devoted to original papers, which will be distinguished in Full articles, Scientific letter, Educational clinical case, Case Reports and Letters to Editor.

Publication of Case Reports is not a primary scope of this Journal and will represent a limited quote of papers published. They will be considered only when they significantly expand the field of general medical knowledge and/or contribute to acknowledging the pathophysiology of the disease. The rarity of the disease is not considered a criterium of priority. Case reports of a puzzling diagnosis, well documented and having a prevalent educational character will be assigned to the section MJHID Educational Clinical Case. Clinical trials of hematological and infectious diseases of Mediterranean area will have their natural home in this Journal. Papers with translational research strictly correlated to clinical problems will also be considered.

Peer Review Process

The articles are reviewed by two external reviewers and by the Editor in Chief/Guest Editor or a member of the Editorial Board. Authors can suggest 2 or more reviewers; moreover, in any case, the editor in chief or/and the guest editor will peer review all manuscript. Furthermore, two reviewers will be consulted. If the reviewers are in disagreement, a third reviewer will be asked. In any case, the final decision will be made by the editor. The first decision will be done within six weeks. If the author is unhappy with the decision, he can propose an independent reviewer, with proved experience in the field (Publications in peer review journals).

Publication Frequency

All the articles will be published in small groups as soon as they are ready, by adding them to the "current" volume,  every two months. Two topical reviews series having one or two guest editors will be planned every year. The items concerning the reviews series will be published when accepted, and then collected at the end of the year to be found together also on their own site.

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Mediterranean Journal of Hematology and Infectious Diseases

Editor in Chief: Giuseppe Leone, Rome, Italy

The Journal publishes original articles and reviews concerning both clinical hematology and infectious diseases. Particular attention will be reserved for original manuscripts focusing on the relationship between blood and infectious diseases. Authors of reviews-articles of relevant and timely subjects are solicited by the Editor in Chief or by the Guest Editor of Reviews Series.  However, Authors, who have reputed original publications in journals covered by SCOPUS and or Web of Science on the field, can submit a review article independently, but they should previously send a summary to the Editor in Chief obtaining his approval. In any case, any manuscript will be submitted to revision and could be rejected.

Scientific Letters: We encourage the submission of significant new findings that fit into the format of a letter. Start the letter with a paragraph summarizing the rationale for the study and the major conclusions. The initial statement of this paragraph will be utilized as abstract and headline. Scientific Letters have a maximum of 2000 words in the text (excluding title, affiliations, figures legends or references), a maximum of 3 tables and/or figures, and only 20 essential references. Letters will appear in the table of contents, have a DOI and be indexed in PubMed.


Clinical cases represent a fixed and limited quote of MJHID publications and are published in different sections.

 Case reports describe one to three patients or a single family. They are taken into consideration only when expanding the field of general medical knowledge and/or physiopathology of the disease. The rarity of the case is not regarded as a criterium of priority.

Educational Clinical  Cases. In this section, the MJHID  presents clinical cases with a puzzling diagnosis, clarified step by step with appropriate documentation.

 Letter to Editor. Letters to the Editor may be used in primis to comment articles appeared in MJHID and to give an opinion or suggestions about topics recently treated in the MJHID, giving original data. Clinical cases making reference to previously published full papers in MJHID  can be taken into consideration as a letter to Editor.


Sources of Support

Journal History

The Mediterranean Journal of Hematology and Infectious Diseases has been founded by Giuseppe Leone, Professor of Hematology at the Catholic University of Rome in 2009, with the Collaboration of Prof.s Eligio Pizzigallo, infectivologist, and Luigi Maria Larocca Pathologist.